Pharmalys Laboratories
Pharmalys Laboratories is a Swiss company specialized in infant nutrition through manufacturing,distribution and promotion of premium infant formulas and baby food in more than 50 countries worldwide.Pharmalys Laboratories is renowned for its premium infant formulas and baby food products, which are distributed in over 50 countries worldwide. This partnership has enabled Lamst Alhaya to provide Libyan families with access to high-quality infant nutrition solutions.
Primalac Premium products
Primalac Premium products assure infants and toddlers are given the best possible start in life. The Primalac Premium range provides a complete balance of essential nutrients. All Primalac Premium formulas are based on the latest research data and legal standards and are produced according to Swiss quality guidelines, using freshmilk from Swiss and Dutch cows.
Nutri-Med
Nutri-Med, GmbH, a renowned German company based in Hamburg, is recognized for its expertise in the development, marketing, and supply of high-quality supplements and OTC products. With a focus on innovation and consumer health, Nutri-Med offers a diverse range of supplements, including vitamins, minerals, and herbal products, designed to promote overall well-being.
Through its collaboration with Ansamalshifa, Nutri-Med has successfully expanded its reach to the Libyan market. This partnership has introduced a variety of health products aimed at enhancing preventive care and meeting the growing demand for supplements in Libya, thereby broadening Ansamalshif ‘s portfolio with trusted and scientifically-backed solutions
CENTOGENE
CENTOGENE specializes in diagnosing and treating rare genetic diseases through a data-driven approach. By utilizing extensive genomic data and cutting-edge analytics, they provide early, precise medical diagnoses, allowing for better treatment outcomes. Their focus on transforming complex genetic information into actionable insights has positioned CENTOGENE as a global leader in rare disease research.
For Ansamalshif, partnering with CENTOGENE has greatly enhanced its ability to offer advanced diagnostic solutions to the Libyan healthcare system. By providing access to CENTOGENE’s world-class genetic testing and data analysis capabilities, Ansamalshif can support physicians in making more informed decisions, leading to earlier diagnoses and tailored treatments for patients with rare genetic diseases.
UNIMED
UNIMED is one of the pioneering pharmaceutical laboratories in Tunisia, known for its commitment to innovation and quality in the healthcare sector. Over the years, UNIMED has significantly expanded its product range, which now includes a variety of specialized medical solutions. These products encompass ophta-ORL (ophthalmology and otorhinolaryngology) solutions, liquids for injection, penicillin powders, and cephalosporins for injection.
The partnership between UNIMED and Ansamalshif has been instrumental in advancing ophthalmology solutions. This collaboration has ensured consistent access to essential eye care products, fostered innovation leading to new and improved ophthalmic solutions, and maintained high standards through rigorous quality control.
CSL Behring
CSL Behring is a global leader in the biopharmaceutical industry, specializing in the development and delivery of innovative therapies for people with rare and serious conditions. With a focus on immunology, hematology, respiratory, and cardiovascular therapies, CSL Behring’s mission is to improve the quality of life for patients worldwide. The company produces a range of life-saving treatments, including plasma- derived therapies, recombinant proteins, and gene therapies.
The partnership between Ansamalshif and CSL Behring holds immense importance, bringing cutting-edge therapies and global expertise to Lamst Alhaya’s mission of improving patient care. By collaborating with CSL Behring, Ansamalshif can provide innovative treatments for rare and serious conditions, such as immunological disorders, hemophilia, and other rare diseases.
Hizentra
is a subcutaneous immunoglobulin (IG) therapy used for patients with primary immunodeficiency diseases (PID) or certain autoimmune conditions.Indications: Hizentra is primarily indicated for the treatment of patients with PID and for maintaining adequate immunoglobulin levels in patients with certain autoimmune diseases, such as chronic inflammatory demyelinating polyneuropathy (CIDP).
Rhophylac
is an injection containing Rh immunoglobulin (anti-D). It’s used to prevent Rh sensitization in Rh-negative individuals:
- Pregnancy: Given to Rh-negative women during and after pregnancy to prevent hemolytic disease of the newborn.
- Transfusions: Used when an Rh-negative person receives Rh-positive blood by mistake.
Alburex
is a human albumin solution used in various medical conditions to help restore and maintain blood volume. Here’s a concise overview:
Indications: Used to treat hypovolemia (low blood volume), hypoalbuminemia (low albumin levels), and conditions like burns, trauma, or sho
Privigen
is an intravenous immunoglobulin (IVIG) therapy used to treat immune system disorders.
Indications: Used for patients with primary immunodeficiency (PID), chronic inflammatory demyelinating polyneuropathy (CIDP), and immune thrombocytopenia (ITP).
Germany line
- Fibrogammin: A coagulation factor for treating bleeding disorders.
- Haemocomplettan: Used in blood clotting.
- Hepatitis B Immunoglobulin: Provides passive immunity against Hepatitis B.
- Haemate: Treats hemophilia.
- Berirab: Rabies immunoglobulin.
- Tetagam: Tetanus immunoglobulin.
- Afstyla: A recombinant factor VIII for hemophilia A.
- Idelvion: A factor IX for hemophilia B.
Our Amazing Partners
